|
Orthologous residues
|
|
SF1 (human): S80‑p, SF1 iso4 (human): S80‑p, SF1 iso5 (human): S205‑p, SF1 iso6 (human): S80‑p, SF1 (mouse): S80‑p, SF1 iso2 (mouse): S80‑p, SF1 (rat): S80‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, mutation of modification site, phosphopeptide mapping
|
|
Relevant cell lines - cell types - tissues:
293 (epithelial), WEHI-231 (B lymphocyte)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
KIS (human)
|
transfection of inactive enzyme
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Effect of modification (process):
RNA splicing, altered
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
U2AF2 (human)
|
|
Induces
|
|
RNA splicing, altered
|
co-immunoprecipitation
|
|
|
Comments:
facilitates formation of the SF1-U2AF-RNA complex
|